posted on 2023-08-01, 11:01authored byMairead Kearney, Liu Zhang, Elizabeth Hubscher, Mihaela Musat, Sharada Harricharan, Thomas Wilke
Supplementary figure and tables
Supplementary Table 1. PICOS criteria
Supplementary Table 2. SLR search strategy
Supplementary Table 3. NST study summary by category
Supplementary Table 4. Risk of bias via modified Newcastle-Ottawa Scale
Supplementary Table 5. List of included studies and reported NST or attrition rates
Supplementary Table 6. Records selected at full-text stage but not extracted due to 1) not specifying period when data was acquired, or 2) not reporting NST or attrition rates
Funding
Merck (CrossRef Funder ID: 10.13039/100009945), (Grant / Award Number: ) Pfizer, (Grant / Award Number: )